For research use only. Not for therapeutic Use.
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].
| Catalog Number | I042413 |
| CAS Number | 357613-86-6 |
| Purity | ≥95% |
| Reference | [1]. Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8. |
